Recent evidence indicates that adult MMR-deficient glioblastomas, including those with Lynch syndrome, may cluster with pediatric-type high-grade gliomas rather than conventional adult GBMs71, are often hypermutated, and may respond to immune checkpoint blockade. This evidence concerns the gene MRC1 and central nervous system cancer.